Belite Bio (BLTE) Assets Average (2023 - 2026)
Belite Bio (BLTE) posted quarterly Assets Average of $795.9 million for Q1 2026, up 403.21% year-over-year from $158.2 million in Q1 2025, and up 49.76% quarter-over-quarter from $531.5 million in Q4 2025.
Belite Bio (BLTE) Assets Average (2023 - 2026) Analysis & Trends
Belite Bio's Assets Average history runs 4 years deep, the most recent figure standing at $795.9 million for Q1 2026.
- In Q1 2026, Assets Average rose 403.21% year-over-year to $795.9 million; the TTM figure through Mar 2026 stood at $795.9 million (up 403.21% YoY), while the FY2025 annual figure was $466.3 million, up 277.95% from the prior year.
- Assets Average for Q1 2026 stood at $795.9 million, up from $531.5 million in the prior quarter.
- The five-year high for Assets Average was $795.9 million in Q1 2026, with the low at $42.0 million in Q1 2023.
- The 4-year median for Assets Average is $117.1 million (2024), against an average of $196.3 million.
- The sharpest annual moves came in 2025 and 2026: Assets Average surged 46.01% in 2025, then soared 403.21% in 2026.
- Belite Bio's Assets Average stood at $76.1 million in 2023, then soared by 76.01% to $134.0 million in 2024, then surged by 296.69% to $531.5 million in 2025, then soared by 49.76% to $795.9 million in 2026.
- Business Quant data shows BLTE's Assets Average at $795.9 million in Q1 2026, $531.5 million in Q4 2025, and $219.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | 795.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 795.91 Mn |
| Dec 31, 2025 | 531.47 Mn |
| Sep 30, 2025 | 219.40 Mn |
| Jun 30, 2025 | 160.30 Mn |
| Mar 31, 2025 | 158.17 Mn |
| Dec 31, 2024 | 133.98 Mn |
| Sep 30, 2024 | 117.13 Mn |
| Jun 30, 2024 | 109.79 Mn |
| Mar 31, 2024 | 97.89 Mn |
| Dec 31, 2023 | 76.12 Mn |
| Sep 30, 2023 | 59.15 Mn |
| Jun 30, 2023 | 50.26 Mn |
| Mar 31, 2023 | 42.05 Mn |